ERMA — Enorama Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Enorama Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	SAS	SAS	—	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	14.6	4.73	12.2	4.14	6.15
Net Total Accounts Receivable
Net Total Receivables	1.94	5.99	8.41	3.42	1.5
Total Inventory
Prepaid Expenses
Total Current Assets	18	12.8	22.4	11.8	13
Net Property, Plant And Equipment	1.63	2.83	2.22	1.54	0.862
Net Intangible Assets
Other Long Term Assets
Total Assets	42.6	40.9	50.9	48.7	34.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.4	18.6	11.7	12.4	10.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	35.4	39.1	29.6	17.2	14.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	7.18	1.78	21.4	31.5	19.5
Total Liabilities & Shareholders' Equity	42.6	40.9	50.9	48.7	34.4
Total Common Shares Outstanding